Related Experiment Video
Updated: Jun 19, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
TOXIC SUBSTANCES PRODUCED BY PNEUMOCOCCUS
1Hospital of The Rockefeller Institute for Medical Research, New York.
Abstract:
1. The filtered blood serum of rabbits infected with pneumococci is not toxic. 2. Extracts of pneumococci prepared by keeping emulsions of the bacteria in salt solution at 37 degrees C. for varying periods of time may be toxic, and when injected intravenously into guinea pigs, may produce a train of symptoms followed by acute death resembling that seen in acute anaphylaxis. Such extracts, however, are not uniformly toxic and it has been impossible to discover the exact conditions under which such extracts become toxic. 3. When the centrifugalized peritoneal washings of guinea pigs infected with pneumococci are injected into the circulation of normal guinea pigs, these animals very frequently exhibit symptoms like those seen in acute anaphylaxis, and a considerable proportion of the animals die acutely. 4. When pneumococci are dissolved in dilute solutions of bile salts and the solution resulting is injected intravenously into rabbits and guinea pigs, these animals show with great constancy the same symptoms that are seen in acute anaphylaxis. The solution of pneumococci in bile may occur in ten minutes at 37 degrees C. or in half an hour on ice. This is considered evidence that the toxicity of the solution does not result from digestion of the bacterial protein, but is due to substances preformed in the bacterial cells and set free on their solution. The toxicity of the solution is diminished or destroyed by heating to 55 degrees C. or over.
Insights
Pneumococci extracts and peritoneal washings can induce anaphylaxis-like symptoms in animals. Dissolving pneumococci in bile salts consistently causes toxicity, suggesting preformed bacterial substances are responsible.
Area of Science:
- Microbiology
- Immunology
- Toxicology
Background:
- Pneumococci are a significant bacterial pathogen.
- Understanding bacterial toxicity mechanisms is crucial for developing treatments.
Purpose of the Study:
- To investigate the toxic effects of pneumococci preparations in animal models.
- To identify the source and nature of pneumococcal toxicity.
Main Methods:
- Injected filtered rabbit serum, pneumococcal extracts, and peritoneal washings into guinea pigs and rabbits.
- Dissolved pneumococci in bile salt solutions and administered intravenously.
- Assessed toxicity through observed symptoms and mortality rates.
- Investigated the effect of heat on toxicity.
Main Results:
- Filtered pneumococcal serum was non-toxic.
- Pneumococcal extracts showed variable toxicity, causing anaphylaxis-like symptoms and death.
- Peritoneal washings induced frequent anaphylaxis-like reactions and mortality.
- Bile salt solutions of pneumococci consistently produced anaphylaxis-like symptoms and death in tested animals.
- Toxicity was linked to preformed bacterial substances, not protein digestion.
- Heating above 55°C reduced or abolished toxicity.
Conclusions:
- Pneumococci contain toxic substances that can elicit severe anaphylaxis-like reactions.
- Bile salt solutions effectively release these preformed toxins.
- Heat inactivation demonstrates the proteinaceous nature of the toxic components.
More Related Videos
07:27Methods for Detecting Cytotoxic Amyloids Following Infection of Pulmonary Endothelial Cells by Pseudomonas aeruginosa
Published on: July 12, 2018
06:05Using the Overlay Assay to Qualitatively Measure Bacterial Production of and Sensitivity to Pneumococcal Bacteriocins
Published on: September 30, 2014
Related Concept Videos
Pneumonia I: Introduction
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology
Atypical Pneumonia
Pneumonia III: Complications and Assessment
Bacterial Meningitis II: Pathophysiology